Cargando…
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also...
Autores principales: | Sahebnasagh, Adeleh, Avan, Razieh, Saghafi, Fatemeh, Mojtahedzadeh, Mojataba, Sadremomtaz, Afsaneh, Arasteh, Omid, Tanzifi, Asal, Faramarzi, Fatemeh, Negarandeh, Reza, Safdari, Mohammadreza, Khataminia, Masoud, Rezai Ghaleno, Hassan, Habtemariam, Solomon, Khoshi, Amirhosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439639/ https://www.ncbi.nlm.nih.gov/pubmed/32816200 http://dx.doi.org/10.1007/s43440-020-00152-9 |
Ejemplares similares
-
The prophylaxis and treatment potential of supplements for COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020) -
A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020) -
Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases
por: Sahebnasagh, Adeleh, et al.
Publicado: (2022) -
Effect of heart rate control with amiodarone infusion on hemodynamic and clinical outcomes in septic shock patients with tachycardia: a prospective, single-arm clinical study
por: Khataminia, Masoud, et al.
Publicado: (2021) -
Prevention of radiotherapy-related oral mucositis with zinc and polyherbal mouthwash: a double-blind, randomized clinical trial
por: Sahebnasagh, Marzieh, et al.
Publicado: (2023)